Ligand id: 7453

Name: crofelemer

IUPHAR Pharmacology Education Project (PEP) logo

View more information in the IUPHAR Pharmacology Education Project: crofelemer

No information available.
Summary of Clinical Use
Crofelemer is approved as an anti-diarrheal medication for use in HIV/AIDS patients, and is not to be used for treating diarrhea caused by viral or bacterial infection.
Mechanism Of Action and Pharmacodynamic Effects
Crofelemer inhibits intestinal chloride ion transport by inhibiting two unrelated chloride channels expressed in luminal membrane enterocytes, namely the cystic fibrosis transmembrane conductance regulator (CFTR) and CaCC (ANO1, a calcium-activated chloride channel) [2]. Inhibition of intestinal chloride excretion is accompanied by decreased passive excretion of sodium ions and water. This reduces the water entering the intestinal lumen, improves stool consistency and reduces diarrheal symptoms.
External links